Reents Scott T 4
4 · AbbVie Inc. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock, $0.01 par value
2024-02-23$61.36/sh+14,140$867,630→ 41,205 total - Sale
Common Stock, $0.01 par value
2024-02-23$177.44/sh−14,140$2,509,002→ 27,065 total - Tax Payment
Common Stock, $0.01 par value
2024-02-28$178.99/sh−11,634$2,082,370→ 15,431 total - Exercise/Conversion
Option (Right to buy)
2024-02-23$61.36/sh−14,140$867,630→ 17,380 totalExercise: $61.36From: 2018-02-16Exp: 2027-02-15→ Common Stock (14,140 underlying)
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.41 to $177.55, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.